GOZAHID Signs Strategic MICE Agreement with Global Pharma Leader Lilly

GOZAHID is proud to announce a new strategic agreement with Lilly, a leading global pharmaceutical company founded in 1876, operating in over 120 countries, and known for its innovation in diabetes, oncology, immunology, and neuroscience. Under this agreement, GOZAHID Business Travel’s MICE department will provide full-service support for Lilly’s Meetings, Incentives, Conferences, and Events, including logistics, travel, venue coordination, and execution.

Lilly is behind some of the world’s most impactful medicines, including:

• Mounjaro (Tirzepatide): A groundbreaking treatment for type 2 diabetes and obesity.

• Trulicity (Dulaglutide): A widely prescribed injectable for diabetes management.

• Verzenio (Abemaciclib): An advanced therapy for breast cancer.

• Taltz (Ixekizumab): Used for plaque psoriasis and other autoimmune conditions.

This partnership reinforces GOZAHID’s position as a trusted provider of travel and event management solutions, aligned with the standards of world-class organizations.